P525: LONG-TERM OUTCOMES OF STEM CELL TRANSPLANT IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX + HMA THERAPIES
Keith Pratz,
Courtney Dinardo,
Martha L Arellano,
Michael Thirman,
Vinod Pullarkat,
Pamela S. Becker,
B. Douglas Smith,
Meng Zhang,
Michael E Werner,
Jalaja Potluri,
Daniel A. Pollyea
Affiliations
Keith Pratz
1 Abramson Cancer Center University of Pennsylvania, Division of Hematology and Oncology, Philadelphia, United States
Courtney Dinardo
2 The University of Texas MD Anderson Cancer Center, Department of Leukemia, Division of Cancer Medicine, Houston, United States
Martha L Arellano
3 Emory University School of Medicine, Department of Hematology and Oncology, Atlanta, United States
Michael Thirman
4 The University of Chicago Medicine, Section of Hematology and Oncology, Department of Medicine, Chicago, United States
Vinod Pullarkat
5 City of Hope National Medical Center, Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, Duarte, United States
Pamela S. Becker
5 City of Hope National Medical Center, Department of Hematology and Hematopoietic Cell Transplantation and Gehr Family Center for Leukemia Research, Duarte, United States
B. Douglas Smith
7 Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Balitmore, United States
Meng Zhang
8 AbbVie Inc, North Chicago, United States
Michael E Werner
8 AbbVie Inc, North Chicago, United States
Jalaja Potluri
8 AbbVie Inc, North Chicago, United States
Daniel A. Pollyea
9 University of Colorado School of Medicine, Division of Hematology, Aurora, United States
